Relay Therapeutics (RLAY) Non-cash Items (2019 - 2025)

Relay Therapeutics (RLAY) has 6 years of Non-cash Items data on file, last reported at $4.8 million in Q4 2025.

• Non-cash Items for Q4 2025 came in at $4.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $4.8 million (changed N/A YoY), and the FY2025 annual result was $4.8 million, changed N/A from the prior year.
• Non-cash Items declined to $4.8 million in Q4 2025 per RLAY's latest filing, from $9.8 million in the prior quarter.
• Over five years, Non-cash Items peaked at $45.9 million in Q4 2021 and troughed at $4.8 million in Q4 2025.
• A 4-year average of $23.8 million and a median of $22.2 million in 2022 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items decreased 24.54% in 2022, then sank 71.69% in 2023.
• A 4-year view of Non-cash Items shows it stood at $45.9 million in 2021, then declined by 24.54% to $34.6 million in 2022, then slumped by 71.69% to $9.8 million in 2023, then plunged by 51.19% to $4.8 million in 2025.
• Business Quant data shows RLAY's Non-cash Items at $4.8 million in Q4 2025, $9.8 million in Q4 2023, and $34.6 million in Q4 2022.